Houston Chronicle by Todd Ackerman April 4, 2020
Houston Methodist Hospital transfused blood from recovered COVID-19 patients into two additional severely ill patients Friday, the same day the federal government made it easier for people afflicted with the coronavirus to receive the experimental therapy.
Doctors offered the therapy to the new patients just before the Food and Drug Administration approved a clinical trial that allows research hospitals to transfuse patients without applying for permission each time, Methodist said in a news release.
Four total patients at Methodist now have received what’s known as convalescent serum therapy, a concept that dates back to the 1918 Spanish flu pandemic. Methodist appeared to become the nation’s first hospital to try the approach in COVID-19 patients when it transfused the blood plasma of a recovered patient into two patients in critical condition March 28.
The hospital Friday said that the patients are still alive, but provided no more detail on their condition.
More:
https://www.houstonchronicle.com/news/houston-texas/houston/article/Methodist-transfuses-blood-into-2-more-COVID-19-15178447.php